Precision medicine

The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map

Kidney discard rates are higher than ever – but the procurement biopsies that often rule out their use are unreliable and need to be standardized

Higher tumor mutational burden is linked to improved survival across multiple cancer types.

Simultaneous multiplex immunohistochemistry can provide efficient testing of multiple targets when diagnosing and selecting treatment for cancer

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

David Rimm challenges the sensitivity and reproducibility of a new assay for PD-L1 detection.

Techniques like droplet digital PCR technology can assist with early monitoring of cancer immunotherapy to ensure the right treatment for each patient

Genomic research has a diversity problem that could restrict the future effectiveness of precision medicine for minority groups

Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions

Decentralized genomic testing in China will allow earlier breast cancer diagnosis and more personalized treatment decisions